Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Federal Judge to Consider Causation Evidence on Link Between Talc and Ovarian Cancer Next Summer August 21, 2018 Austin Kirk Add Your Comments A U.S. District Judge presiding over thousands of federal Baby Powder lawsuits and Shower-to-Shower lawsuits filed against Johnson & Johnson, will determine next summer whether plaintiffs have sufficient evidence about the link between talc and ovarian cancer to continue with the claims. There are currently more than 8,200 product liability lawsuits pending against Johnson & Johnson in the federal court system, each involving similar allegations that women were diagnosed with ovarian cancer following years of applying the company’s talcum powder products around their genitals for “feminine hygiene”. Plaintiffs allege that Johnson & Johnson has known that talc causes ovarian cancer for decades, yet continued to market their products to adult women, promoting use for “personal freshness” and to mask odors. Learn More About Talcum Powder Lawsuits Talcum powder or talc powder may cause women to develop ovarian cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Talcum Powder Lawsuits Talcum powder or talc powder may cause women to develop ovarian cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Most of the cases originated in state court systems, including Missouri and California, where a number of early “bellwether” trials have already resulted in massive, multi-million dollar verdicts against Johnson & Johnson for providing false and misleading information to consumers. However, following a Supreme Court ruling last year that drastically changed the landscape of state court litigation for product liability claims, thousands of talc powder cases were removed from state courts to the federal court system, where the lawsuits are pending as part of a multidistrict litigation (MDL) before U.S. District Judge Freda L. Wolfson in the District of New Jersey. Prior to moving forward with bellwether trials in the MDL, Judge Wolfson has indicated that the court will rule on general causation challegnes, determining whether plaintiffs have sufficiently reliable scientific evidence that talcum powder exposure causes cancer. In a case management order (PDF) issued earlier this month, Judge Wolfson laid out the schedule for the handling of general causation experts and Daubert challenges to the admissibility of expert witness testimony. A decision about the admissibility of plaintiffs’ evidence in the federal court system may come as early as next summer under the schedule. The order indicates that most samples testing for general causation expert reports should be completed by October 1, with the expert reports themselves served by plaintiffs on or before November 16. Defendants have until December 17 to complete any depositions of the plaintiffs general causation experts. Likewise, defendants have until February 15, 2019 to submit their causation expert reports, and plaintiffs have until March 18, 2019 to complete depositions on those experts. The deadline for filing Daubert motions regarding general causation has been set for April 18, 2019, with the motions to be heard on June 11, 2019. While the federal litigation proceeds on this track, additional state-court cases against Johnson & Johnson are expected to go to trial in the coming months and years. Johnson & Johnson has already been hit with massive verdicts from several state court juries. The largest came last month, when a Missouri jury ordered Johnson & Johnson to pay $4.7 billion to a group of 22 women whose cases were tried together. That verdict included more than $4 billion in punitive damages, designed to punish the company and deter reckless behavior in regards to women’s health. Some analysts that the verdicts in several early trial dates may provide troubling signals for Johnson & Johnson in the talcum powder litigation, suggesting that juries find the company’s trial defense lacking in credibility. Ultimately, if the company fails to negotiate talcum powder settlements for women with ovarian cancer or otherwise resolve the litigation, thousands of individual cases may be set for trials nationwide in the federal court system in the coming years. Tags: Baby Powder, Cancer, Johnson & Johnson, Missouri, Ovarian Cancer, Shower to Shower, Talc, Talcum Powder Image Credit: | More Talcum Powder Lawsuit Stories Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL July 3, 2025 Talcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial July 1, 2025 Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions June 20, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)